tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

CRL Stock Latest News

Charles River price target lowered to $260 from $280 at Credit Suisse
The FlyCharles River price target lowered to $260 from $280 at Credit Suisse
26d ago
CRL
Guggenheim upgrades Charles River, sees buying opportunity in pullback
The FlyGuggenheim upgrades Charles River, sees buying opportunity in pullback
26d ago
CRL
Charles River price target lowered to $260 from $280 at Citi
The FlyCharles River price target lowered to $260 from $280 at Citi
26d ago
CRL
Charles River upgraded to Buy from Neutral at Guggenheim
The FlyCharles River upgraded to Buy from Neutral at Guggenheim
26d ago
CRL
Charles River Plunges after Monkey Troubles Set In
Market NewsCharles River Plunges after Monkey Troubles Set In
26d ago
CRL
Charles River falls -14.5%
The FlyCharles River falls -14.5%
26d ago
CRL
Charles River falls -10.1%
The FlyCharles River falls -10.1%
26d ago
CRL
Charles River falls -11.3%
The FlyCharles River falls -11.3%
26d ago
CRL
Charles River sees Q1 adjusted EPS down mid single digits y/y, consensus $2.62
The FlyCharles River sees Q1 adjusted EPS down mid single digits y/y, consensus $2.62
27d ago
CRL
Charles River not providing FY23 FCF, CapEx outlooks at this time
The FlyCharles River not providing FY23 FCF, CapEx outlooks at this time
27d ago
CRL
Charles River receives U.S. Department of Justice subpoena for NHP supply chain
The FlyCharles River receives U.S. Department of Justice subpoena for NHP supply chain
27d ago
CRL
Charles River sees FY23 EPS $9.70-$10.90, consensus $11.37
The FlyCharles River sees FY23 EPS $9.70-$10.90, consensus $11.37
27d ago
CRL
Charles River reports Q4 EPS $2.98, consensus $2.75
The FlyCharles River reports Q4 EPS $2.98, consensus $2.75
27d ago
CRL
Charles River acquires SAMDI Tech for $50M cash
The FlyCharles River acquires SAMDI Tech for $50M cash
2M ago
CRL
iVexSol closes $23.8M Series A-3 financing
The FlyiVexSol closes $23.8M Series A-3 financing
2M ago
BMY
CRL
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
2M ago
BA
BK
Charles River establishes eXpDNA plasmid manufacturing platform
The FlyCharles River establishes eXpDNA plasmid manufacturing platform
2M ago
CRL
Charles River downgraded to Hold at Jefferies on NHP risks
The FlyCharles River downgraded to Hold at Jefferies on NHP risks
2M ago
CRL
Charles River downgraded to Hold from Buy at Jefferies
The FlyCharles River downgraded to Hold from Buy at Jefferies
2M ago
CRL
Early notable gainers among liquid option names on January 11th
The FlyEarly notable gainers among liquid option names on January 11th
2M ago
BIO
CRL
Charles River price target raised to $285 from $275 at Baird
The FlyCharles River price target raised to $285 from $275 at Baird
2M ago
CRL
Charles River not aware of NHP export restrictions, says Evercore ISI
The FlyCharles River not aware of NHP export restrictions, says Evercore ISI
3M ago
CRL
Charles River rises 8.8%
The FlyCharles River rises 8.8%
3M ago
CRL
Early notable gainers among liquid option names on December 15th
The FlyEarly notable gainers among liquid option names on December 15th
3M ago
VZ
CRL
Charles River could be hurt by NHP supply challenges in FY23, says BofA
The FlyCharles River could be hurt by NHP supply challenges in FY23, says BofA
4M ago
CRL
Bust of smuggling ring likely to beheadwind for LabCorp, says Wells Fargo
The FlyBust of smuggling ring likely to beheadwind for LabCorp, says Wells Fargo
4M ago
LH
CRL
Charles River says not named or referenced in DOJ proceedings
The FlyCharles River says not named or referenced in DOJ proceedings
4M ago
CRL
Society for Immunotherapy of Cancer to hold a meeting
The FlySociety for Immunotherapy of Cancer to hold a meeting
4M ago
LH
BMY
Society for Immunotherapy of Cancer to hold a meeting
The FlySociety for Immunotherapy of Cancer to hold a meeting
4M ago
LH
BMY
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.